Jazz Pharmaceuticals Stock Target Raised

UBS raises Jazz Pharmaceuticals stock target to $307 UBS upgraded Jazz Pharmaceuticals two notches, from neutral to buy, and lifted its price target to $307 from $188. This represents a 63% jump in one move, and it sits well above the prior analyst consensus of roughl